D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4251
CALL
Arbor Realty Trust
ABR
$973M
| $278K | ﹤0.01% |
+15,000
| New | +$271K |
|
|
ESPR
4252
DELISTED
Esperion Therapeutics
ESPR
| $278K | ﹤0.01% |
+23,079
| New | +$336K |
|
4253
Grocery Outlet
GO
$932M
| $278K | ﹤0.01% |
+12,893
| New | +$371K |
|
4254
PUT
PVH
PVH
$3.83B
| $278K | ﹤0.01% |
2,700
| – | – |
|
|
SEEL
4255
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $276K | ﹤0.01% |
30
+6
| +25% | +$51.6K |
|
4256
Noodles & Co
NDLS
$90.3M
| $275K | ﹤0.01% |
2,916
-5,178
| -64% | -$507K |
|
4257
TFS Financial
TFSL
$5.1B
| $275K | ﹤0.01% |
+14,453
| New | +$282K |
|
|
NUVL
4258
DELISTED
Nuvalent
NUVL
| $274K | ﹤0.01% |
+12,142
| New | +$352K |
|
4259
SELLAS Life Sciences
SLS
$2.2B
| $274K | ﹤0.01% |
29,921
-2,193
| -7% | -$20.3K |
|
4260
SelectQuote
SLQT
$120M
| $273K | ﹤0.01% |
+21,112
| New | +$318K |
|
|
AAT
4261
American Assets Trust
AAT
$1.51B
| $272K | ﹤0.01% |
+7,280
| New | +$276K |
|
4262
Acumen Pharmaceuticals
ABOS
$160M
| $272K | ﹤0.01% |
+18,314
| New | +$305K |
|
|
ARGO
4263
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $272K | ﹤0.01% |
5,208
+115
| +2% | +$6.04K |
|
4264
Enpro
NPO
$6.74B
| $271K | ﹤0.01% |
3,105
| – | – |
|
4265
CRH
CRH
$67.7B
| $270K | ﹤0.01% |
5,769
-20,869
| -78% | -$1.06M |
|
4266
Mercury Insurance
MCY
$6B
| $270K | ﹤0.01% |
4,855
-15,150
| -76% | -$905K |
|
|
PRTK
4267
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $270K | ﹤0.01% |
55,507
-51,401
| -48% | -$283K |
|
4268
PUT
Bank of Montreal
BMO
$124B
| $269K | ﹤0.01% |
+2,700
| New | +$272K |
|
4269
Orion Group Holdings
ORN
$491M
| $268K | ﹤0.01% |
49,263
-37,255
| -43% | -$204K |
|
4270
Royal Caribbean
RCL
$78.7B
| $268K | ﹤0.01% |
3,009
-293,785
| -99% | -$23.8M |
|
|
WW
4271
DELISTED
WW International
WW
| $268K | ﹤0.01% |
14,677
+8,443
| +135% | +$221K |
|
|
CLYM
4272
Climb Bio
CLYM
$739M
| $268K | ﹤0.01% |
+14,912
| New | +$308K |
|
4273
Victory Capital Holdings
VCTR
$6.14B
| $267K | ﹤0.01% |
7,625
-18,664
| -71% | -$622K |
|
4274
Ducommun
DCO
$2.65B
| $266K | ﹤0.01% |
5,282
+1,096
| +26% | +$57.5K |
|
4275
Comfort Systems
FIX
$58.4B
| $266K | ﹤0.01% |
3,728
-387
| -9% | -$28.8K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.